Estrogen treatment increases mitochondrial mass, the DNA-binding activity of NRF1, a regulator of TFAM, and the level of TFAM, and TFAM shRNA inhibits colony formation in E2-treated breast cancer cells. The gene discussed is NRF1; the disease is breast cancer.